Myomo (MYO) Non Operating Investment Income (2022 - 2023)
Myomo's (MYO) quarterly Non Operating Investment Income came in at -$70124.0 in Q3 2023, down 321.11% YoY from $31713.9 in Q3 2022, and down 460.36% on a QoQ basis from -$12514.0 in Q2 2023.
Myomo (MYO) Non Operating Investment Income (2022 - 2023) Analysis & Trends
Myomo (MYO) has 2 years of Non Operating Investment Income data on file, last reported at -$70124.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | - |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | - |
| 10 | Myomo | 72.11 Mn | 53.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -70,124.00 |
| Sep 30, 2023 | -70,124.00 |
| Jun 30, 2023 | -12,514.00 |
| Jun 30, 2023 | -12,514.00 |
| Sep 30, 2022 | -16,652.00 |
| Sep 30, 2022 | -16,652.00 |
| Jun 30, 2022 | -33,208.00 |
| Jun 30, 2022 | -33,208.00 |